Search results for: HTA
Filter search results
Generating Preference-based Values for the EQ-5D-Y to Support Its Use in HTA
31 January 2019
…EQ-5D-Y to support its use in HTA from Office of Health Economics For more information, please contact Koonal Shah. Herdman, M., Cole, A., Hoyle, C. K., Coles, V., Carroll,…
The BRAVER Roadmap to Broader Assessment of the Value of Health Interventions in the Asia-Pacific Region
14 April 2025
…societal perspectives and broader value elements into HTA decision-making in the APAC region. It focuses on three dimensions: Willingness for Recognition in HTA Guidelines: the motivation and readiness of HTA…
OHE in the Spotlight: Summer 2011
22 September 2011
…and participation in a discussion session at the HTAi Annual Meeting. One poster focused on the evolution of HTA in Brazil and the other on understanding the evolution of HTA…
Incorporating the Patient Voice in Health Technology Assessment
15 February 2024
…to facilitate this consideration; and HTA bodies should give patients a direct voice in HTA recommendations The patient voice matters in HTA decision-making because it ensures that healthcare assessments and…
HTA and Appropriate Drug Pricing Worldwide
9 September 2011
The August 2011 issue of Health Affairs featured four articles on how and why pricing for pharmaceuticals differs from one country to another. The OHE’s Prof Adrian Towse co-authored the…
Understanding the Full Value of Long-Acting Therapies: less is more?
7 May 2025
…HTA agencies. HTA value frameworks risk under-recognising the broader value of LA therapies. The potential for benefits in key areas such as patient choice, productivity gains, and environmental impact are…
Bridging the Gap: Pathways for Regulatory and Health Technology Assessment of Histology Independent Cancer Treatments
8 January 2021
…cancer therapies that require reconsideration of HTA methods/processes. When asked how HTA/payers should evolve the evaluation framework to accommodate those therapies and address unmet patient needs, 73% of 116 respondents…
Cost-effectiveness Analysis of Gene Therapies for Inherited Eye Disease: Are Current Discounting Approaches Too Short-sighted?
15 February 2023
…discount rate and to the discounting method in deliberative decision-making. The emphasis on deliberative decision-making varies across HTA settings. It should be an essential part of the HTA process for…